Another Paragon spinout goes public through reverse merger

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 13 Oct, 20:35 UTC

One lawyer involved noted how it's yet another example of Paragon and key investor Fairmount — which have helped transform the reputation for reverse mergers — quickly executing on a complicated deal.

science

Sources

• T2Another Paragon spinout goes public through reverse mergerBioPharma Dive / Healthcare Dive / MedTech Dive13 Oct, 20:35